DK3606929T3 - Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme - Google Patents

Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme Download PDF

Info

Publication number
DK3606929T3
DK3606929T3 DK18781797.8T DK18781797T DK3606929T3 DK 3606929 T3 DK3606929 T3 DK 3606929T3 DK 18781797 T DK18781797 T DK 18781797T DK 3606929 T3 DK3606929 T3 DK 3606929T3
Authority
DK
Denmark
Prior art keywords
beta
preparation
methods
same
nicotinate ester
Prior art date
Application number
DK18781797.8T
Other languages
English (en)
Inventor
Anthony A Sauve
Original Assignee
Univ Cornell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell filed Critical Univ Cornell
Application granted granted Critical
Publication of DK3606929T3 publication Critical patent/DK3606929T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/02Phosphorylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048Pyridine radicals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
DK18781797.8T 2017-04-05 2018-04-05 Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme DK3606929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762481912P 2017-04-05 2017-04-05
PCT/US2018/026209 WO2018187540A1 (en) 2017-04-05 2018-04-05 Beta-nicotinate ester nucleotides and processes for preparing same

Publications (1)

Publication Number Publication Date
DK3606929T3 true DK3606929T3 (da) 2021-08-23

Family

ID=63712318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18781797.8T DK3606929T3 (da) 2017-04-05 2018-04-05 Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme

Country Status (18)

Country Link
US (2) US10961268B2 (da)
EP (1) EP3606929B1 (da)
JP (1) JP7182289B2 (da)
KR (1) KR102605369B1 (da)
CN (1) CN110709406B (da)
AU (2) AU2018250242B2 (da)
CA (1) CA3059228A1 (da)
CY (1) CY1124450T1 (da)
DK (1) DK3606929T3 (da)
ES (1) ES2887224T3 (da)
HR (1) HRP20211296T1 (da)
HU (1) HUE055521T2 (da)
LT (1) LT3606929T (da)
PL (1) PL3606929T3 (da)
PT (1) PT3606929T (da)
RS (1) RS62284B1 (da)
SI (1) SI3606929T1 (da)
WO (1) WO2018187540A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1957086B1 (en) 2005-11-18 2018-05-02 Cornell Research Foundation, Inc. Nicotinoyl riboside compositions and methods of use
CA2994553C (en) 2015-08-05 2022-08-30 Metro International Biotech, Llc Nicotinamide mononucleotide derivatives and their uses
CA3059228A1 (en) 2017-04-05 2018-10-11 Cornell University .beta.-nicotinate ester nucleotides and processes for preparing same
WO2020072497A1 (en) * 2018-10-01 2020-04-09 Cornell University Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
CA3219033A1 (en) 2021-05-27 2022-12-01 Metro International Biotech, Llc Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use
CN113527376A (zh) * 2021-08-06 2021-10-22 上海昶法新材料有限公司 β-烟酰胺单核苷酸的制备方法
WO2023122190A1 (en) * 2021-12-22 2023-06-29 Metro International Biotech, Llc Compositions for treatment of inflammation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3736314A (en) * 1967-06-02 1973-05-29 Syntex Corp Unsaturated nucleoside phosphonates phosphonic acids and phosphonic acid salts
EP1957086B1 (en) 2005-11-18 2018-05-02 Cornell Research Foundation, Inc. Nicotinoyl riboside compositions and methods of use
WO2011003018A2 (en) 2009-07-01 2011-01-06 Cornell University Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof
US9603862B2 (en) 2009-12-14 2017-03-28 Cornell University Activation and activators of SIRT5
WO2011081945A2 (en) 2009-12-14 2011-07-07 Cornell University Activation and activators of sirt6
US9290791B2 (en) 2010-05-18 2016-03-22 Cornell University Reagents and methods for sirtuin capture
ES2785303T3 (es) 2012-07-16 2020-10-06 Univ Cornell Nicotinamida ribósido para tratar la pérdida auditiva
RU2016149767A (ru) * 2014-06-06 2018-07-16 Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед Аналоги никотинамидрибозида и фармацевтические композиции и их применение
US20160035539A1 (en) * 2014-07-30 2016-02-04 Lauri SAINIEMI Microfabrication
EP3256137B1 (en) 2015-02-10 2019-11-13 Duke University Method of treating heart failure
CN107613990B (zh) 2015-03-27 2021-03-26 康奈尔大学 烟酰胺单核苷酸的有效合成
EP3302059A4 (en) * 2015-06-04 2018-10-03 Chromadex, Inc. Selective solvent free phosphorylation
EP3322419A4 (en) 2015-07-15 2018-08-01 Cornell University Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
CA3059228A1 (en) 2017-04-05 2018-10-11 Cornell University .beta.-nicotinate ester nucleotides and processes for preparing same
WO2020072497A1 (en) 2018-10-01 2020-04-09 Cornell University Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof

Also Published As

Publication number Publication date
HRP20211296T1 (hr) 2021-11-12
AU2018250242A1 (en) 2019-10-31
US10961268B2 (en) 2021-03-30
US11530233B2 (en) 2022-12-20
AU2018250242B2 (en) 2021-07-15
PT3606929T (pt) 2021-09-02
LT3606929T (lt) 2021-10-25
WO2018187540A1 (en) 2018-10-11
HUE055521T2 (hu) 2021-11-29
US20200031860A1 (en) 2020-01-30
SI3606929T1 (sl) 2021-11-30
US20210214386A1 (en) 2021-07-15
CN110709406B (zh) 2022-11-08
CY1124450T1 (el) 2022-07-22
KR20190137133A (ko) 2019-12-10
AU2021250984A1 (en) 2021-11-18
AU2021250984B2 (en) 2022-09-01
JP2020516619A (ja) 2020-06-11
ES2887224T3 (es) 2021-12-22
CA3059228A1 (en) 2018-10-11
EP3606929A4 (en) 2020-05-06
RS62284B1 (sr) 2021-09-30
KR102605369B1 (ko) 2023-11-24
PL3606929T3 (pl) 2021-12-27
EP3606929A1 (en) 2020-02-12
EP3606929B1 (en) 2021-06-02
CN110709406A (zh) 2020-01-17
JP7182289B2 (ja) 2022-12-02

Similar Documents

Publication Publication Date Title
DK3882357T3 (da) Fremgangsmåder og sammensætninger til analyse af nukleinsyrer
DK3606929T3 (da) Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme
DK3782639T3 (da) Sammensætninger og fremgangsmåder til internalisering af enzymer
DK3303317T3 (da) Fremgangsmåder og sammensætninger til inhibering af interaktionen af menin med MLL-proteiner
DK3307872T3 (da) Fremgangsmåder og sammensætninger til effektiv indgivelse af nukleinsyrer og rna-baserede antimikrober
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3286181T3 (da) Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3185868T3 (da) Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3350201T3 (da) Manipulerede fytaser og fremgangsmåder til anvendelse af samme
DK3701973T3 (da) Plasmabaseret film og fremgangsmåder til fremstilling og anvendelse af samme
DK3155101T3 (da) Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3178324T3 (da) Mikrobicid og fremgangsmåde til fremstilling af samme
DK3607050T3 (da) Ex vivo-dyrkningssystem og metoder til brugen af samme
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3307878T3 (da) Fremgangsmåder til fremstilling og oprensning af nukleinsyreholdige sammensætninger
DK3200748T3 (da) Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted
DK3265443T3 (da) Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme